GSI 7985 (Harvoni ledipasvir 90 mg / sofosbuvir 400 mg)

Generic Name: ledipasvir/sofosbuvir

Pill with imprint GSI 7985 is Orange, Four-sided and has been identified as Harvoni ledipasvir 90 mg / sofosbuvir 400 mg. It is supplied by Gilead Sciences, Inc..

Harvoni is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Harvoni ledipasvir 90 mg / sofosbuvir 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 7985

Harvoni

Generic Name

ledipasvir/sofosbuvir

Imprint

GSI 7985

Strength

ledipasvir 90 mg / sofosbuvir 400 mg

Color

Orange

Shape

Four-sided

Availability

Prescription only

Drug Class

Antiviral combinations

Pregnancy Category

B - No proven risk in humans

CSA Schedule

Not a controlled drug

Labeler / Supplier

Gilead Sciences, Inc.

National Drug Code (NDC)

61958-1801

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer